Dermal Fillers
REVANESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 11119
Revanesse Versa™+
In stock
Volume
2 x 1,2 mL
Laboratory
Prollenium Medical Technologies Inc.
Origin
Canada
Indication
Facial line smoothing and volume enhancement
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Revanesse Versa+ is a biocompatible, sterile, injectable hydrogel from Prollenium Medical Technologies in Aurora, Canada, based on bioresorbable cross-linked hyaluronic acid at 25 mg/mL containing 0.3% lidocaine. It is indicated for injection into the mid to deep dermis for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults 22 years of age or more. The gel is delivered in a pre-filled disposable glass syringe, two 1.2 mL syringes per box with two sterile needles, and it is FDA approved.
Key Benefits of Revanesse Versa™+
- Bioresorbable cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
- Indicated for moderate to severe facial wrinkles and folds, such as nasolabial folds
- Placed in the mid to deep dermis
- FDA approved for the cosmetic treatment of facial wrinkles and creases
- Supported by a randomised, multicentre, double-blind split-face study of 100 patients
- Delivered in pre-filled disposable glass syringes, two 1.2 mL per box with two sterile needles
Indications and Professional Use
Main indications
- Correction of moderate to severe facial wrinkles and folds
- Nasolabial folds
Professional use
For professional use. Revanesse Versa+ is injected by qualified, trained doctors into the dermis of the patient, and is not for retail sale or self-administration. It is intended for intradermal use only and must not be injected into blood vessels: unintentional intravascular injection is rare but its complications can be serious and may be permanent, including vision abnormalities, blindness, stroke, temporary scabs and permanent scarring of the skin. Stop immediately and seek specialist assessment if the patient shows changes in vision, signs of a stroke, white appearance of the skin, or unusual pain during or shortly after treatment. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing, and confirm the box seal is unbroken and the product in date before use.
Treatment areas
- Face
- Nasolabial folds
Patient profile
Indicated for adults 22 years of age or more seeking correction of moderate to severe facial wrinkles and folds. It should not be used in patients who are pregnant or breastfeeding, as safety in these groups has not been studied; who have a history of hypertrophic scarring or keloid formation; who have evidence of scars at the intended treatment sites; who have acne or other inflammatory skin diseases such as rosacea, seborrhoeic dermatitis or psoriasis; or who have an allergic history including severe allergic reactions, atopy, allergy to hyaluronic acid products, or allergy to streptococcal proteins. Treatment should also be deferred where there is an active inflammatory process such as pimples, hives, rashes or cysts, until it has resolved.
How Revanesse Versa™+ Works
Versa+ is injected into the dermis using a variety of techniques, placing a small portion of the gel beneath a crease or wrinkle in the skin; the augmentation of the tissue produces a smoothing effect at the surface. The hyaluronic acid is a naturally occurring substance produced by bacteria and purified for use as an injectable soft tissue filler. Because the gel is bioresorbable, the correction is temporary rather than permanent. The 0.3% lidocaine is present for injection comfort.
Why Order From Allpara
Allpara offers genuine, verified REVANESSE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
What clinical evidence supports Revanesse Versa+?
A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.
Is Versa+ CE marked?
Its instructions for use are the United States document and carry no CE mark. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.
Where can clinics buy Revanesse Versa+?
ALLPARA supplies Revanesse Versa+ to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Prollenium Medical Technologies
Clinic alternatives
/ Recently viewed
Pick up where you left off
Revanesse Versa™+
In stock
CE Marked
Revanesse Versa+ is a biocompatible, sterile, injectable hydrogel from Prollenium Medical Technologies in Aurora, Canada, based on bioresorbable cross-linked hyaluronic acid at 25 mg/mL containing 0.3% lidocaine. It is indicated for injection into the mid to deep dermis for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults 22 years of age or more. The gel is delivered in a pre-filled disposable glass syringe, two 1.2 mL syringes per box with two sterile needles, and it is FDA approved.
Key Benefits of Revanesse Versa™+
- Bioresorbable cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
- Indicated for moderate to severe facial wrinkles and folds, such as nasolabial folds
- Placed in the mid to deep dermis
- FDA approved for the cosmetic treatment of facial wrinkles and creases
- Supported by a randomised, multicentre, double-blind split-face study of 100 patients
- Delivered in pre-filled disposable glass syringes, two 1.2 mL per box with two sterile needles
Indications and Professional Use
Main indications
- Correction of moderate to severe facial wrinkles and folds
- Nasolabial folds
Professional use
For professional use. Revanesse Versa+ is injected by qualified, trained doctors into the dermis of the patient, and is not for retail sale or self-administration. It is intended for intradermal use only and must not be injected into blood vessels: unintentional intravascular injection is rare but its complications can be serious and may be permanent, including vision abnormalities, blindness, stroke, temporary scabs and permanent scarring of the skin. Stop immediately and seek specialist assessment if the patient shows changes in vision, signs of a stroke, white appearance of the skin, or unusual pain during or shortly after treatment. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing, and confirm the box seal is unbroken and the product in date before use.
Treatment areas
- Face
- Nasolabial folds
Patient profile
Indicated for adults 22 years of age or more seeking correction of moderate to severe facial wrinkles and folds. It should not be used in patients who are pregnant or breastfeeding, as safety in these groups has not been studied; who have a history of hypertrophic scarring or keloid formation; who have evidence of scars at the intended treatment sites; who have acne or other inflammatory skin diseases such as rosacea, seborrhoeic dermatitis or psoriasis; or who have an allergic history including severe allergic reactions, atopy, allergy to hyaluronic acid products, or allergy to streptococcal proteins. Treatment should also be deferred where there is an active inflammatory process such as pimples, hives, rashes or cysts, until it has resolved.
How Revanesse Versa™+ Works
Versa+ is injected into the dermis using a variety of techniques, placing a small portion of the gel beneath a crease or wrinkle in the skin; the augmentation of the tissue produces a smoothing effect at the surface. The hyaluronic acid is a naturally occurring substance produced by bacteria and purified for use as an injectable soft tissue filler. Because the gel is bioresorbable, the correction is temporary rather than permanent. The 0.3% lidocaine is present for injection comfort.
Why Order From Allpara
Allpara offers genuine, verified REVANESSE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
What clinical evidence supports Revanesse Versa+?
A randomised, multicentre, double-blind, split-face study enrolling 100 patients across four sites compared Versa+ against a comparator for correction of nasolabial folds, treating one fold on each side of the face. Subjects were followed for a total of 12 months, with open-label retreatment available at 6 months.
Is Versa+ CE marked?
Its instructions for use are the United States document and carry no CE mark. Versa+ is approved for use in the U.S. by the Food and Drug Administration for the cosmetic treatment of facial wrinkles and creases.
Where can clinics buy Revanesse Versa+?
ALLPARA supplies Revanesse Versa+ to licensed practitioners, clinics and distributors on a B2B account. Wholesale terms, stock position and batch expiry are released to registered professional buyers.
More from Prollenium Medical Technologies
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.